B-PRECURSOR ALL
Clinical trials for B-PRECURSOR ALL explained in plain language.
Never miss a new study
Get alerted when new B-PRECURSOR ALL trials appear
Sign up with your email to follow new studies for B-PRECURSOR ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New engineered cell therapy tested in kids with Tough-to-Treat cancers
Disease control CompletedThis study tested a new type of personalized cell therapy for children and young adults whose leukemia or lymphoma had come back or did not respond to standard treatments. Researchers collected a patient's own immune cells, genetically modified them in a lab to recognize a protei…
Matched conditions: B-PRECURSOR ALL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Gentler combo therapy tested to fight leukemia in older patients
Disease control CompletedThis study tested a new treatment plan for older adults (55-75) newly diagnosed with a fast-growing blood cancer called B-cell acute lymphoblastic leukemia (ALL). The goal was to see if using a lower dose of standard chemotherapy, followed by an immunotherapy drug called blinatum…
Matched conditions: B-PRECURSOR ALL
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC